Ferring Pharmaceuticals Unveils Six-Month Efficacy Data for EUFLEXXA(R) for the Treatment of Osteoarthritis Knee Pain
Microtest Labs Adds Dissolution Testing to its Suite of Analytical and Stability Testing Services
Procter & Gamble Wins Patent Infringement Lawsuit for Osteoporosis Therapy Actonel
FDA Approves ACTOplus met(R) XR (pioglitazone HCl and metformin HCl extended-release) Tablets for the Treatment of Type 2 Diabetes
AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure
Addrenex Pharmaceuticals Expands Product Pipeline by Licensing New Drug to Treat Narcolepsy
Santarus to Webcast Analyst Day and Investor Briefing Presentation on May 13
ACLU Challenges Patents on Breast Cancer Genes
Procter & Gamble Announces National Launch of Align with Bifantis - The Gold Standard of Probiotic Supplements
PRA International: Participating Sponsor for Exploratory Clinical Development World in London
Interleukin Genetics to Chair Expert Panel Discussion on Use of Biomarkers in Drug Development at BIO Convention
Roche Announces Long-Term Commitment to Tackle Growing Epidemic of Diabetes
Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content. Terms and conditions, including restrictions on redistribution, apply. Copyright © 1996-2009 PR Newswire Association LLC. All Rights Reserved. A United Business Media company.